Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04080882 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands
A Phase 2 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT04080882: Completed Phase 2 study, sponsored by Galderma R&D.
NCT04080882 is a Phase 2 study that has completed, run by Galderma R&D. The registered enrollment target is 80 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04080882, a Phase 2 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
Interventional phase 2 study to evaluate safety and efficacy of abobotulinumtoxinA for the treatment of platysmal bands.
Primary Outcome
A responder is defined as a subject who achieves grade 1 or 2 in platysmal band severity on the Investigator Live Assessment (ILA).
Interventions
- OTHER Placebo
- BIOLOGICAL AbobotulinumtoxinA dose 3
- BIOLOGICAL AbobotulinumtoxinA dose 1
- BIOLOGICAL AbobotulinumtoxinA dose 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-09-25 |
| Est. Completion | 2020-06-04 |
| Phase | Phase 2 |
What the finished NCT04080882 record still lists
NCT04080882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT04080882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04080882 about?
NCT04080882 is a clinical study titled "Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands". Interventional phase 2 study to evaluate safety and efficacy of abobotulinumtoxinA for the treatment of platysmal bands.
What is the current status of trial NCT04080882?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2019-09-25. Estimated completion is 2020-06-04.
What interventions are being tested in trial NCT04080882?
The interventions under investigation include: Placebo (OTHER), AbobotulinumtoxinA dose 3 (BIOLOGICAL), AbobotulinumtoxinA dose 1 (BIOLOGICAL), AbobotulinumtoxinA dose 2 (BIOLOGICAL).
Who is sponsoring clinical trial NCT04080882?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04080882's enrollment target sits among peer trials
80 842nd of 2000 higher than 1,117 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI